Journal article · 2008 · Open access
Developing drugs that can cross the blood-brain barrier: applications to Alzheimer's disease
BMC Neuroscience, 9(S3), S2 · Published 1 December 2008 · DOI 10.1186/1471-2202-9-s3-s2
In brief
“Developing drugs that can cross the blood-brain barrier: applications to Alzheimer's disease” is a 2008 journal article by William A. Banks, published in BMC Neuroscience. OpenAlex counts 56 citations as of 21 November 2026. It is open access under a CC BY licence: the full text is free to read at BMC Neuroscience.
- Citations
- 56
- Most cited in
- 2018 (5)
- Field-weighted impact
- 1.74
- References
- 10
- Authors
- 1
Abstract
Development of therapeutics for the central nervous system is one of the most challenging areas in drug development. This is primarily because, in addition to all of the other complications one faces in developing new drugs targeting peripheral sites, one must also negotiate the blood-brain barrier (BBB). There are dozens of strategies to overcome the obstacle of the BBB, but many of these are bound to fail, barring extreme serendipity, because they are based on an inaccurate or incomplete picture of the BBB. This article therefore starts with a brief review of the BBB as it pertains to drug development. It then examines some examples of the delivery of drugs to the central nervous system that are relevant to Alzheimer's disease, placing emphasis on peptides, antibodies, and antisense oligonucleotides.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Banks, W. A. (2008). Developing drugs that can cross the blood-brain barrier: applications to Alzheimer's disease. BMC Neuroscience, 9(S3), S2. https://doi.org/10.1186/1471-2202-9-s3-s2
MLA 9
Banks, William A. “Developing drugs that can cross the blood-brain barrier: applications to Alzheimer's disease.” BMC Neuroscience, vol. 9, no. S3, 2008, p. S2. https://doi.org/10.1186/1471-2202-9-s3-s2.
Chicago
Banks, William A. 2008. “Developing drugs that can cross the blood-brain barrier: applications to Alzheimer's disease.” BMC Neuroscience 9 (S3): S2. https://doi.org/10.1186/1471-2202-9-s3-s2.
Harvard
Banks, W. A. (2008) ‘Developing drugs that can cross the blood-brain barrier: applications to Alzheimer's disease’, BMC Neuroscience, 9(S3), p. S2. doi:10.1186/1471-2202-9-s3-s2.
IEEE
W. A. Banks, “Developing drugs that can cross the blood-brain barrier: applications to Alzheimer's disease,” BMC Neuroscience, vol. 9, no. S3, p. S2, 2008, doi: 10.1186/1471-2202-9-s3-s2.
BibTeX
@article{banks2008developing,
title = {{Developing drugs that can cross the blood-brain barrier: applications to Alzheimer's disease}},
author = {Banks, William A.},
journal = {BMC Neuroscience},
year = {2008},
volume = {9},
number = {S3},
pages = {S2},
doi = {10.1186/1471-2202-9-s3-s2},
url = {https://doi.org/10.1186/1471-2202-9-s3-s2}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2014 | 2 | |
| 2015 | 2 | |
| 2017 | 3 | |
| 2018 | 5 | |
| 2019 | 3 | |
| 2020 | 1 | |
| 2021 | 5 | |
| 2022 | 5 | |
| 2023 | 2 | |
| 2024 | 5 |
Its field-weighted citation impact is 1.74: it has been cited 1.74 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- blood-brain barrier
- Alzheimer's disease
- brain drug delivery
- blood-brain barrier permeability
- peptides
- immunoglobulins
- antisense oligonucleotides
Work with this paper
Most-cited papers in Neuroscience
- The Rat Brain in Stereotaxic CoordinatesGeorge Paxinos, CHARLES R. R. WATSON · Elsevier eBooks · 1982 · 52,413 citations
- The assessment and analysis of handedness: The Edinburgh inventoryRichard Charles Oldfield · Neuropsychologia · 1971 · 36,725 citations
- EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysisArnaud Delorme A, Scott Makeig · Journal of Neuroscience Methods · 2004 · 25,302 citations
- The Ecological Approach to Visual PerceptionMarc H. Bornstein, James J. Gibson · Journal of Aesthetics and Art Criticism · 1980 · 22,977 citations
- The Psychophysics ToolboxDavid H. Brainard · Spatial Vision · 1997 · 20,208 citations
Questions about this paper
How do I cite this paper in APA style?
Banks, W. A. (2008). Developing drugs that can cross the blood-brain barrier: applications to Alzheimer's disease. BMC Neuroscience, 9(S3), S2. https://doi.org/10.1186/1471-2202-9-s3-s2
How many times has this paper been cited?
56 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at BMC Neuroscience: sign in and open the PDF from this page.
Who wrote this paper?
William A. Banks.
What is the DOI of this paper?
10.1186/1471-2202-9-s3-s2, permanently at https://doi.org/10.1186/1471-2202-9-s3-s2. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.